Header Logo

Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.

Brekelmans MP, Bleker SM, Bauersachs R, Boda Z, B├╝ller HR, Choi Y, Gallus A, Grosso MA, Middeldorp S, Oh D, Raskob G, Schwocho L, Cohen AT. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. Thromb Haemost. 2016 07 04; 116(1):155-61.

View in: PubMed